![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, April 05, 2014 2:26:12 AM
Was unaware you were BB44, Been following that Yahoo board for a long while, although never post. I like it better over here, seems more sane. I really like your posts, and DD over there though, it's awesome, and appreciated. It's very nice to see you posting over here now. I just noticed a post today that caught my attention.
What does OncoSec have to offer:
NeoPulse:
Ready for market in Europe
CE Mark for Europe,
Patent for China for method of use and device.
ImmunoPulse:
Patent Protection through 2024
Phase 2 Malignant Melanoma, planned Phase 2B combo w/ anti-PD-1(potential BD and AA)
Phase 2 Merkel Cell Carcinoma (potential OD/OA)
Phase 2 Cutaneous T-cell Lymphoma
Regarding Cutaneous T-Cell Lymphoma. I'm under the impression, and have been under the impression for a couple years that this is also a potential OD/AA type indication. I believe I read it in an interview with Punit, and a Seeking Alpha author a couple years back. Can you, or anyone confirm? I think we all think about Merkel, but forget about Cutaneous T-Cell, and it's potential. Hasn't been an update on this trial in a looooong time, just saying. :) $ONCS
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM